Endocrinology, Vol 136, 1934-1938, Copyright © 1995 by Endocrine Society

ARTICLES

Glucose-6-phosphatase activity in islets from ob/ob and lean mice and the effect of dexamethasone

A Khan, C Hong-Lie and BR Landau
Department of Molecular Medicine, Karolinska Hospital, Stockholm, Sweden.

In previous studies we demonstrated a much greater rate of glucose cycling (glucose-->glucose-6-P-->glucose) in islets from ob/ob mice than from lean litter mates. Cycling was further augmented by dexamethasone treatment. To determine whether these findings could be accounted for by increased islet glucose-6-phosphatase activity, we have now measured that enzyme's activity in permeabilized and sonicated islets and in islet microsomes. Activity in permeabilized islets from ob/ob mice was 19 times more than from lean litter mates (17.7 +/- 2.9 vs. 0.9 +/- 0.2 pmol/islet/min). Activity was 6 times higher when calculated per microgram of protein or microgram of DNA. Treatment of ob/ob mice with dexamethasone (25 micrograms/daily for 3 days) increased activity 2- to 3-fold. Activities were about twice as much in sonicated as permeabilized islets. There was no difference between glucose-6-phosphatase activity in microsomes prepared from islets of ob/ob and from lean mice, and the activity was relatively low. Thus, permeabilized islets can be used to determine glucose-6-phosphatase activity and study its regulation. The higher glucose cycling in islets of ob/ob mice and its stimulation by dexamethasone can be attributed to increased glucose-6-phosphatase activity.

This article has been cited by other articles:

				K. B. Pedersen, P. Zhang, C. Doumen, M. Charbonnet, D. Lu, C. B. Newgard, J. W. Haycock, A. J. Lange, and D. K. Scott The promoter for the gene encoding the catalytic subunit of rat glucose-6-phosphatase contains two distinct glucose-responsive regions Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E788 - E801. [Abstract] [Full Text] [PDF]

				W. Jang and R. H. Gomer Exposure of Cells to a Cell Number-Counting Factor Decreases the Activity of Glucose-6-Phosphatase To Decrease Intracellular Glucose Levels in Dictyostelium discoideum Eukaryot. Cell, January 1, 2005; 4(1): 72 - 81. [Abstract] [Full Text] [PDF]

				A. J. Petrolonis, Q. Yang, P. J. Tummino, S. M. Fish, A. E. Prack, S. Jain, T. F. Parsons, P. Li, N. A. Dales, L. Ge, et al. Enzymatic Characterization of the Pancreatic Islet-specific Glucose-6-Phosphatase-related Protein (IGRP) J. Biol. Chem., April 2, 2004; 279(14): 13976 - 13983. [Abstract] [Full Text] [PDF]

				L. J. Bischof, C. C. Martin, C. A. Svitek, B. T. Stadelmaier, L. A. Hornbuckle, J. K. Goldman, J. K. Oeser, J. C. Hutton, and R. M. O’Brien Characterization of the Mouse Islet-Specific Glucose-6-Phosphatase Catalytic Subunit-Related Protein Gene Promoter by In Situ Footprinting: Correlation With Fusion Gene Expression in the Islet-Derived {beta}TC-3 and Hamster Insulinoma Tumor Cell Lines Diabetes, March 1, 2001; 50(3): 502 - 514. [Abstract] [Full Text]

				A. J. Weinhaus, N. V. Bhagroo, T. C. Brelje, and R. L. Sorenson Dexamethasone Counteracts the Effect of Prolactin on Islet Function: Implications for Islet Regulation in Late Pregnancy Endocrinology, April 1, 2000; 141(4): 1384 - 1393. [Abstract] [Full Text] [PDF]

				S. Gremlich, R. Roduit, and B. Thorens Dexamethasone Induces Posttranslational Degradation of GLUT2 and Inhibition of Insulin Secretion in Isolated Pancreatic beta Cells. COMPARISON WITH THE EFFECTS OF FATTY ACIDS J. Biol. Chem., February 7, 1997; 272(6): 3216 - 3222. [Abstract] [Full Text] [PDF]

				C. C. Martin, L. J. Bischof, B. Bergman, L. A. Hornbuckle, C. Hilliker, C. Frigeri, D. Wahl, C. A. Svitek, R. Wong, J. K. Goldman, et al. Cloning and Characterization of the Human and Rat Islet-specific Glucose-6-phosphatase Catalytic Subunit-related Protein (IGRP) Genes J. Biol. Chem., June 29, 2001; 276(27): 25197 - 25207. [Abstract] [Full Text] [PDF]